MedTrace Logo

Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)

NCT06935747 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-04-24

No results posted yet for this study

Summary

The general objective of this split-mouth study is to analyze the osteogenic action of BTCP during the bone regeneration process following the extraction of impacted mandibular third molars.

Conditions

  • Bone Loss
  • Regenerative Inflammation
  • Third Molars Extraction

Interventions

COMBINATION_PRODUCT

Medical device: beta-tricalcium phosphate

The description of the intervention for BTCP in the study involves the application of this substance to promote bone regeneration following the extraction of impacted mandibular third molars. BTCP is indicated for the treatment of segmental and cavitary bone loss, aesthetic repairs, and bone augmentations (such as inlay or onlay grafts); for filling dental alveolar bone; for dental implant placement; and for the stabilization of osteotomies and prostheses in dentistry.

OTHER

Bovine Hydroxyapatite

The intervention description for Bio-Oss in the study involves the application of this standard material to promote bone regeneration following the extraction of impacted mandibular third molars. Bio-Oss is a commonly used xenograft material known for its osteoconductive properties.

Sponsors & Collaborators

  • Universidad de Murcia

    collaborator OTHER

  • Nueva Galimplant SLU

    collaborator UNKNOWN

  • Mario Pérez Sayáns

    lead OTHER

Principal Investigators

  • Fabio Camacho Alonso, phD · Universidad de Murcia

  • Abel García García, phD · Universidade de Santiago de Compostela

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2026-03-31
Completion
2026-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06935747 on ClinicalTrials.gov